One in Six Children on GLP-1 Drugs Develop Nutritional Deficiency, Study Finds
A new analysis of insurance claims reveals that nearly 17% of adolescents taking GLP-1 medications for weight loss or diabetes develop a diagnosed nutritional shortfall within a year.
Share this story
For parents helping their teenagers navigate weight loss or diabetes with GLP-1 medications, the daily routine now requires a much closer look at the dinner plate. According to a comprehensive new analysis of medical records, nearly one in six adolescents on these drugs develops a diagnosed nutritional deficiency within their first year of treatment.
The reality of a medically suppressed appetite means that families can no longer rely on sheer volume of food to deliver essential vitamins, fundamentally changing how they must approach mealtime and grocery shopping to protect their child's health.[1][2][4]
The findings, published September 17, 2026, in the journal Childhood Obesity, turn a spotlight on the hidden cost of a suddenly shrunken appetite. When a child simply stops feeling hungry, the few bites they do take need to work much harder to supply the calcium, iron, and vitamins required for their growing bodies. This shifts the focus of pediatric weight management from simply reducing caloric intake to actively ensuring that the calories consumed carry enough essential micronutrients to sustain healthy development.[4]
To understand how these medications affect growing bodies, researchers combed through a massive pool of United States insurance claims from 2017 through 2022. They zeroed in on 2,031 children and teenagers, aged 10 to 17, who had just started a GLP-1 receptor agonist and had a clean bill of nutritional health beforehand.
By tracking these patients over time, the study authors aimed to uncover whether the dramatic reduction in food intake triggered by the drugs was inadvertently starving these adolescents of the basic building blocks they need during their most critical years of physical maturation.[2][4]
The group—averaging 15 years old and 61.5% female—mostly relied on liraglutide, which accounted for 78.6% of the prescriptions, while dulaglutide and semaglutide made up the rest. Within just six months of their first injection, 10.2% of these young patients were diagnosed with a nutritional shortfall.
By the end of a full year, that number reached 16.88%. These figures highlight a rapid onset of dietary gaps, suggesting that the nutritional reserves of a teenager can be depleted in a matter of months when their daily food intake drops precipitously without a targeted nutritional strategy in place.[2][4]
Vitamin D deficiency was the most frequent hurdle, showing up in 12.4% of the teenagers. Without enough vitamin D, growing bones struggle to absorb calcium, putting skeletal strength at risk during a vital window of development. Nutritional anemia appeared in 1.55% of the teens, and specific iron-deficiency anemia affected another 1.44%.
While those percentages may sound small, they represent real adolescents left vulnerable to chronic fatigue, weakness, and brain fog during crucial school years, all because their reduced diets failed to deliver enough iron to keep their red blood cells functioning properly.[2][4]
The root of the problem lies in how effectively the drugs work. GLP-1 medications slow the emptying of the stomach and signal profound fullness to the brain, which is exactly why they succeed in treating obesity.
But when a teenager skips breakfast because they feel full and only picks at a sandwich for lunch, they miss out on the baseline micronutrients their bodies expect. The sheer mechanics of the medication mean that casual eating habits are no longer sufficient to support pubertal development, muscle building, and the intensive biological changes that define the teenage years.[1][2]
"As appropriate pediatric use of GLP-1s becomes more widespread, we need to understand the risks during periods of rapid growth and pubertal development," said Justin Ryder, Vice Chair of Research for the Department of Surgery at Ann & Robert H. Lurie Children's Hospital of Chicago and the study's senior author. Ryder's team recognized that while the medications offer a powerful tool against metabolic disease, they also introduce a new variable into pediatric care that doctors and parents have not historically had to manage at this scale.[5]
"Nutrients such as vitamin D, iron and calcium are of particular concern during adolescence, when deficiencies may have lasting implications for skeletal health and overall development," Ryder explained in a Northwestern University release. Because teenagers are actively building the bone density that will carry them through the rest of their lives, a year spent in a severe vitamin deficit is not just a temporary inconvenience; it is a structural risk that requires immediate and sustained intervention from healthcare providers.[5]
Yet, despite these high stakes, very few families are getting a roadmap for how to feed a child who has lost their appetite. The study found that a mere 5.8% of the children sat down with a nutrition counselor within their first 30 days on the medication.
Even after six months, only 23.3% had received professional dietary guidance, and they waited an average of 149 days for that first appointment. This delay leaves parents guessing in the grocery aisle during the exact months when their child's dietary habits are undergoing the most drastic transformation.[2][4]
The data also revealed a counterintuitive twist: teens who saw a nutritionist had higher rates of diagnosed deficiencies (23.2%) than those who navigated the treatment alone (14.8%). Researchers note this likely reflects the reality of medical testing rather than a failure of counseling. Dietitians are the professionals most likely to order the specific blood work that catches missing vitamins, and doctors often only refer a family to a nutritionist after a routine blood test flashes a warning sign, meaning the higher rate is a product of better detection.[4]
The stakes for getting this balance right are immense, as the medical community cannot afford to abandon these therapies. The Centers for Disease Control and Prevention notes that 22% of adolescents aged 12 to 19 currently live with obesity, making effective treatments like GLP-1s a vital tool for long-term health. The goal is not to pull teenagers off the medication, but to modernize the standard of care so that nutritional safeguarding becomes as routine as checking a patient's weight or blood pressure during a follow-up visit.[6]
For families, the research offers a clear, actionable blueprint for the months ahead. Instead of waiting for a teenager to feel exhausted from iron depletion or for a blood test to reveal a severe vitamin D shortage, parents and pediatricians can build a nutrition plan from day one. By ensuring that every smaller meal is anchored by protein, dark leafy greens, and nutrient-dense whole foods, families can harness the benefits of the medication while giving a growing body the essential building blocks it cannot afford to skip.[1][2]
Key points
- Nearly 17% of adolescents on GLP-1 medications developed a nutritional deficiency within one year of starting treatment.
- Vitamin D deficiency was the most common shortfall, affecting 12.4% of the young patients studied.
- Despite the risks to growing bodies, only 5.8% of patients received nutritional counseling within their first 30 days on the drugs.
- Researchers urge doctors to integrate proactive dietary planning into pediatric GLP-1 care rather than waiting for deficiencies to appear.
- Pediatric Researchers
- Advocating for proactive nutritional monitoring as a standard part of GLP-1 treatment.
- Clinical Dietitians
- Focusing on maximizing the nutrient density of smaller meals.
- Public Health Officials
- Balancing the urgent need to treat rising childhood obesity rates against the emerging risks of new pharmaceutical interventions.
Perspectives this story doesn't cover
- Insurance Providers
- Adolescent Patients
Sources
[1]Contemporary PediatricsPediatric ResearchersGLP-1 receptor agonists tied to nutritional deficiencies in children, study finds
Read on Contemporary Pediatrics →
[2]The Pharmaceutical JournalClinical DietitiansChildren taking GLP-1s can be at risk of nutritional deficiencies, study finds
Read on The Pharmaceutical Journal →
[3]LabrootsClinical DietitiansGLP-1 Drugs Linked to Nutritional Deficiencies in Youth
Read on Labroots →
[4]Childhood ObesityPediatric ResearchersNutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists
Read on Childhood Obesity →
[5]Northwestern UniversityPediatric ResearchersGLP-1s linked to nutritional deficiencies in children
Read on Northwestern University →
[6]Centers for Disease Control and PreventionPublic Health OfficialsChildhood Obesity Facts
Read on Centers for Disease Control and Prevention →
More in Lifestyle
See all →Infant Physiology
The Parasympathetic Transport Response: Why Walking Quiets Crying Infants
3 sources
Infant Sleep Safety
How Cervical Flexion in Car Seats Triggers Infant Oxygen Desaturation
5 sources
Infant Hydration
Why Infants Under Six Months Cannot Drink Water
4 sources
Prenatal Health
Major Swedish Study Links Congenital TORCH Infections to Tripled Autism Risk
5 sources
Comments
Every angle. Every day.
Get Lifestyle stories with full source coverage and perspective breakdowns, free every day.




